Crossmark

Which treatment is better than concurrent chemoradiotherapy about survival for stage III or IV locally advanced nasopharyngeal carcinoma? An updated Bayesian network meta-analysis of randomized controlled trials

Crossref DOI link: https://doi.org/10.1007/s00405-021-06614-x

Published Online: 2021-02-17

Published Print: 2021-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fang, Lucheng

Shi, Licai

Wang, Wen

Hu, Tingting

Rao, Xingwang https://orcid.org/0000-0003-3859-0563
License Information

Text and Data Mining valid from 2021-02-17

Version of Record valid from 2021-02-17
More Information

Article History

Received: 2 December 2020

Accepted: 7 January 2021

First Online: 17 February 2021

Compliance with ethical standards

:

: The authors have no conflict of interest.

Document is current

Any future updates will be listed below